billS1255•Event Wednesday, April 2, 2025Analyzed

Cormorant Relief Act of 2025

Bullish

Impact5/10

Archer-Daniels-Midland ($ADM)Bunge Global ($BG)$TSN Agriculture Materials

Summary

The Cormorant Relief Act of 2025 is an early-stage bill that mandates regulatory relief for U.S. aquaculture producers by reissuing and expanding cormorant culling authority. This directly lowers operating costs and fish crop losses for aquaculture farms, benefiting downstream feed suppliers and processors such as $ADM, $BG, and $TSN. At current prices ($ADM $72.8, $BG $126.36, $TSN $64.11), these stocks show mixed near-term momentum but stand to gain from structural cost reduction in the aquaculture supply chain if the bill advances.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

1.S.1255 is an early-stage regulatory relief bill, not a spending authorization — it reduces operational costs for aquaculture producers by expanding cormorant culling authority to 12 new states and private lake/pond managers.
2.Primary beneficiaries are feed suppliers (ADM, BG) and integrated protein producers (TSN) with aquaculture exposure; no direct federal funding is involved.
3.The bill has been stalled in committee for over a year with only 5 Republican sponsors — low probability of passage in the 119th Congress without expanded bipartisan support.

Market Implications

Near-term market impact is minimal given the bill's early legislative stage and one-year stall. ADM, BG, and TSN are not pricing in cormorant relief. The real opportunity emerges if the bill gains committee attention or a floor vote — that would signal higher probability of passage and trigger valuation adjustments for aquaculture-exposed segments. ADM ($72.80) is the most leveraged pure-play on feed volumes and has the strongest recent price momentum (+4.85% 7-day). BG ($126.36) offers aquaculture feed exposure but is also tied to soybean crush margins, which are currently under pressure. TSN ($64.11) has limited upside from this bill alone — aquaculture is a small portion of its diversified protein portfolio. For investors, this is a watch-and-wait catalyst: monitor committee hearings and cosponsor additions. No position warranted at this stage.

Full Analysis

The Cormorant Relief Act of 2025 (S.1255) was introduced in the Senate on April 2, 2025, by Sen. Tom Cotton (R-AR) with four cosponsors (Tuberville, Britt, Hyde-Smith, Wicker). It was read twice and referred to the Committee on Environment and Public Works — an early procedural stage with no further action in the past year. The bill mandates that the Secretary of the Interior reissue the original 2016 depredation order for double-crested cormorants at aquaculture facilities within one year of enactment, expanding it to 12 additional states (CA, CO, CT, IL, IN, IA, MI, MO, NJ, OH, PA, WI) and to private lake and pond managers. This is a regulatory relief mechanism, not a direct spending authorization — it reduces costs by allowing legal culling of predatory birds that eat farmed fish, thereby lowering fish mortality and crop losses for aquaculture producers. The money trail is indirect. The bill authorizes zero federal spending (funding_amount_usd = 0). Instead, it reduces operational costs and production losses for aquaculture businesses, increasing their profitability and potentially expanding production volumes. For upstream suppliers like ADM and BG, which produce animal feed ingredients (soybean meal, specialty proteins), larger aquaculture output means higher feed demand. For Tyson, which operates integrated protein businesses including fish farming, lower mortality directly improves cost of goods sold and margins on existing output. The primary beneficiaries are aquaculture operators in the expanded states, with knock-on demand effects for feed processors. Structural winners are companies with significant aquaculture feed exposure: ADM (animal nutrition segment, ~$5B annual revenue) and BG (specialty feed ingredients, ~$2B in oilseed-based feed). Tyson benefits as an integrated operator but aquaculture is a smaller fraction of its $53B total revenue — the impact is real but secondary. No pure-play U.S. aquaculture public companies exist at meaningful scale, so these diversified agribusiness firms are the best proxies. Real market data (April 28, 2026 close): $ADM at $72.80 (+4.85% 7-day, +0.79% 30-day) shows strong recent momentum, trading near the top of its 52-week range ($46.81–$74.19). $BG at $126.36 (+0.47% 7-day, -1.83% 30-day) is off its recent highs but near mid-range ($71.60–$131.93). $TSN at $64.11 (-0.68% 7-day, +0.30% 30-day) is in the upper half of its 52-week band ($50.56–$66.41). The bill's impact is too early-stage to drive price action — no stock shows unusual volume or price response to this specific legislation. The recent ADM rally is likely driven by broader agricultural commodity trends, not cormorant policy. Timeline: This bill has been stalled for over a year (last action: April 2, 2025). As an introduced bill with only 5 sponsors (all Republicans, no Democrats), it faces significant hurdles to passage in a divided Congress. The next steps are: committee markup (Environment and Public Works), Senate floor vote, companion bill (HR2293 is identical, introduced in the House), conference committee, and presidential signature. Passage probability is low in this congress (119th, 2025–2027) unless it gains bipartisan cosponsors and committee chair support. The addition of 12 states — including California and Illinois — may broaden appeal but also invites opposition from animal welfare and environmental groups.